Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Anja Möricke, Martin Schrappe|Blood|2008Cited by 607
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusKjeld Schmiegelow, Ester Zápotocká, Shlomit Barzilai et al.|The Lancet Oncology|2016Cited by 268